Their study confirmed that GDF-15 increased in 76% of patients with pulmonary hypertension, and found that the increased GDF-15 level was related to older age, higher NYHA level, shorter 6 min walking distance, higher average right atrial pressure, and higher NT-proBNP. Here, GDF15 is linked to pulmonary arterial hypertension.